Apellis Pharmaceuticals Inc (APLS)
42.00
-0.56
(-1.32%)
USD |
NASDAQ |
Jun 14, 16:00
42.00
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Revenue (Annual): 396.59M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 396.59M |
December 31, 2022 | 75.42M |
Date | Value |
---|---|
December 31, 2021 | 66.56M |
December 31, 2020 | 250.65M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
66.56M
Minimum
2021
396.59M
Maximum
2023
197.31M
Average
163.03M
Median
Revenue (Annual) Benchmarks
Blueprint Medicines Corp | 249.38M |
Alnylam Pharmaceuticals Inc | 1.828B |
Cytokinetics Inc | 7.53M |
Madrigal Pharmaceuticals Inc | -- |
Sarepta Therapeutics Inc | 1.243B |